Review
Colorectal Cancer Screening
Fu-Yin Du1,#, Zhi-Qiong Yu1,#, Jie Li1, Ming-Hua Ai1, Xiao-Ping Tan1,*
1Department of Gastroenterology, The First Affiliated Hospital of Yangtze University, 8 Hang Kong Road, Jingzhou, Hubei 434000, China.
#, These authors contributed equally. *, Correspondence Dr Xiaoping Tan, Department of Gastroenterology, The First Affiliated Hospital of Yangtze University, 8 Hang Kong Road, Jingzhou, Hubei 434000, China. E-mail: [email protected]. Received: August 23, 2022; Accepted: October 23, 2022; Published online: November 13, 2022. Cite this paper: Fu-Yin Du, Zhi-Qiong Yu, Jie Li, Ming-Hua Ai, Xiao-Ping Tan. (2021) Colorectal Cancer Screening. Global Journal of Medicine, 3(1):1-26. http://naturescholars.com/gjm.030101. https://doi.org/10.46633/gjm.030101. Copyright © 2022 by Scholars Publishing, LLC.
Abstract
Colorectal cancer (CRC) is a common health problem with a high incidence and mortality rate, but it is also highly preventable. The development of most CRC is a multistep process that includes a series of histological, morphological, and genetic changes. screening for CRC can be of great help in reducing its incidence. Here, we review the history of CRC development, risk factors, characteristics of various screening modalities, and quality indicators of colonoscopy. In addition, we discuss the use of artificial intelligence in CRC screening and interventions to improve screening adherence. However there are many patients eligible for screening who still do not receive screening. Therefore, it is important for primary care physicians to understand the characteristics of various screening modalities to recommend appropriate screening strategies for patients to maximize patient participation, adherence, and quality of screening with the aim of reducing CRC morbidity and mortality.
Keywords
Colorectal Cancer; Screening; Colonoscopy; Fecal Occult Blood Test; Fecal Immunochemical Test.